|
|
Blood, 15 April 2004, Vol. 103, No. 8, pp. 3029-3037.
Prepublished online as a Blood First Edition Paper on January 8, 2004; DOI 10.1182/blood-2003-10-3417.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Tissue factor-factor VIIaspecific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration
Gertrud M. Hjortoe,
Lars C. Petersen,
Tatjana Albrektsen,
Brit B. Sorensen,
Peder L. Norby,
Samir K. Mandal,
Usha R. Pendurthi, and
L. Vijaya Mohan Rao
From the Biomedical Research Division, University of Texas Health Center at Tyler, TX; and Health Care Discovery, Novo Nordisk A/S, Maaloev and Bagsvaerd, Denmark.
Tissue factor (TF), the cellular receptor for factor VIIa (FVIIa), besides initiating blood coagulation, is believed to play an important role in tissue repair, inflammation, angiogenesis, and tumor metastasis. Like TF, the chemokine interleukin-8 (IL-8) is shown to play a critical role in these processes. To elucidate the potential mechanisms by which TF contributes to tumor invasion and metastasis, we investigated the effect of FVIIa on IL-8 expression and cell migration in a breast carcinoma cell line, MDA-MB-231, a cell line that constitutively expresses abundant TF. Expression of IL-8 mRNA in MDA-MB-231 cells was markedly up-regulated by plasma concentrations of FVII or an equivalent concentration of FVIIa (10 nM). Neither thrombin nor other proteases involved in hemostasis were effective in stimulating IL-8 in these cells. Increased transcriptional activation of the IL-8 gene is responsible for increased expression of IL-8 in FVIIa-treated cells. PAR-2specific antibodies fully attenuated TF-FVIIainduced IL-8 expression. Additional in vitro experiments showed that TF-FVIIa promoted tumor cell migration and invasion, active siteinactivated FVIIa, and specific antibodies against TF, PAR-2, and IL-8 inhibited TF-FVIIainduced cell migration. In summary, the studies described herein provide insight into how TF may contribute to tumor invasion. (Blood. 2004;103:3029-3037)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Siegbahn, M. Johnell, A. Nordin, M. Aberg, and T. Velling
TF/FVIIa Transactivate PDGFR to Regulate PDGF-BB Induced Chemotaxis in Different Cell Types: Involvement of Src And PLC
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2008;
28(1):
135 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Versteeg, F. Schaffner, M. Kerver, H. H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B. M. Mueller, and W. Ruf
Inhibition of tissue factor signaling suppresses tumor growth
Blood,
January 1, 2008;
111(1):
190 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. R. Pendurthi, S. Ghosh, S. K. Mandal, and L. V. M. Rao
Tissue factor activation: is disulfide bond switching a regulatory mechanism?
Blood,
December 1, 2007;
110(12):
3900 - 3908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zoudilova, P. Kumar, L. Ge, P. Wang, G. M. Bokoch, and K. A. DeFea
beta-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2
J. Biol. Chem.,
July 13, 2007;
282(28):
20634 - 20646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Wygrecka, P. Markart, C. Ruppert, K. Petri, K. T. Preissner, W. Seeger, and A. Guenther
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs
Eur. Respir. J.,
June 1, 2007;
29(6):
1105 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Awasthi, S. K. Mandal, V. Papanna, L. V. M. Rao, and U. R. Pendurthi
Modulation of Tissue Factor-Factor VIIa Signaling by Lipid Rafts and Caveolae
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2007;
27(6):
1447 - 1455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Arora, T. K. Ricks, and J. Trejo
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer
J. Cell Sci.,
March 15, 2007;
120(6):
921 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sevastos, S. E. Kennedy, D. R. Davis, M. Sam, P. W. Peake, J. A. Charlesworth, N. Mackman, and J. H. Erlich
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury
Blood,
January 15, 2007;
109(2):
577 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koizume, M.-S. Jin, E. Miyagi, F. Hirahara, Y. Nakamura, J.-H. Piao, A. Asai, A. Yoshida, E. Tsuchiya, W. Ruf, et al.
Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII
Cancer Res.,
October 1, 2006;
66(19):
9453 - 9460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ahamed, H. H. Versteeg, M. Kerver, V. M. Chen, B. M. Mueller, P. J. Hogg, and W. Ruf
Disulfide isomerization switches tissue factor from coagulation to cell signaling
PNAS,
September 19, 2006;
103(38):
13932 - 13937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Lane, A. R. Anand, and R. K. Ganju
Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis
Int. Immunol.,
August 1, 2006;
18(8):
1315 - 1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Amarzguioui, Q. Peng, M. T. Wiiger, V. Vasovic, E. Babaie, T. Holen, J. M. Nesland, and H. Prydz
Ex vivo and In vivo Delivery of Anti-Tissue Factor Short Interfering RNA Inhibits Mouse Pulmonary Metastasis of B16 Melanoma Cells.
Clin. Cancer Res.,
July 1, 2006;
12(13):
4055 - 4061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zhu, F. Sennlaub, M. H. Beauchamp, L. Fan, J. S. Joyal, D. Checchin, S. Nim, P. Lachapelle, M. Sirinyan, X. Hou, et al.
Proangiogenic Effects of Protease-Activated Receptor 2 Are Tumor Necrosis Factor-{alpha} and Consecutively Tie2 Dependent
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
744 - 750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Hackeng, K. M. Sere, G. Tans, and J. Rosing
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor
PNAS,
February 28, 2006;
103(9):
3106 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Morris, Y. Ding, T. K. Ricks, A. Gullapalli, B. L. Wolfe, and J. Trejo
Protease-Activated Receptor-2 Is Essential for Factor VIIa and Xa-Induced Signaling, Migration, and Invasion of Breast Cancer Cells
Cancer Res.,
January 1, 2006;
66(1):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Welty-Wolf, M. S. Carraway, T. L. Ortel, A. J. Ghio, S. Idell, J. Egan, X. Zhu, J.-a. Jiao, H. C. Wong, and C. A. Piantadosi
Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure
Am J Physiol Lung Cell Mol Physiol,
January 1, 2006;
290(1):
L21 - L31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Kim, M. Hayashi, J.-F. Lo, C. Fearns, R. Xiang, G. Lazennec, Y. Yang, and J.-D. Lee
Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8
Cancer Res.,
October 1, 2005;
65(19):
8784 - 8791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Johansson, C. Lawson, M. Dabare, D. Syndercombe-Court, A. C. Newland, G. L. Howells, and M. G. Macey
Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1{beta}
J. Leukoc. Biol.,
October 1, 2005;
78(4):
967 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Belting, J. Ahamed, and W. Ruf
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2005;
25(8):
1545 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Noorbakhsh, N. Vergnolle, J. C. McArthur, C. Silva, M. Vodjgani, P. Andrade-Gordon, M. D. Hollenberg, and C. Power
Proteinase-Activated Receptor-2 Induction by Neuroinflammation Prevents Neuronal Death during HIV Infection
J. Immunol.,
June 1, 2005;
174(11):
7320 - 7329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. van Deventer, W. O'Connor Jr., W. J. Brickey, R. M. Aris, J. P.Y. Ting, and J. S. Serody
C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis
Cancer Res.,
April 15, 2005;
65(8):
3374 - 3379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ahamed, M. Belting, and W. Ruf
Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1
Blood,
March 15, 2005;
105(6):
2384 - 2391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2005;
25(1):
47 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ge, S. K. Shenoy, R. J. Lefkowitz, and K. DeFea
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both {beta}-Arrestin-1 and -2
J. Biol. Chem.,
December 31, 2004;
279(53):
55419 - 55424.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|